These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16391885)

  • 1. Sjögren syndrome in a child: favorable response of the arthritis to TNFalpha blockade.
    Pessler F; Monash B; Rettig P; Forbes B; Kreiger PA; Cron RQ
    Clin Rheumatol; 2006 Sep; 25(5):746-8. PubMed ID: 16391885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study.
    Zandbelt MM; de Wilde P; van Damme P; Hoyng CB; van de Putte L; van den Hoogen F
    J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
    Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
    Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term low-dose glucocorticoid therapy associated with remission of overt renal tubular acidosis in Sjögren's syndrome.
    el-Mallakh RS; Bryan RK; Masi AT; Kelly CE; Rakowski KJ
    Am J Med; 1985 Oct; 79(4):509-14. PubMed ID: 4050835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal renal tubular acidosis associated with Sjögren's syndrome.
    Yasuda K; Sasaki K; Yamato M; Hayashi T
    Intern Med; 2012; 51(6):675-6. PubMed ID: 22449687
    [No Abstract]   [Full Text] [Related]  

  • 6. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Hypokalemic Periodic Paralysis Unmasks Sjogren Syndrome without Sicca Symptoms.
    Hung YM; Huang NC; Wann SR; Chang YT; Wang JS
    J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S36-8. PubMed ID: 25933458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
    Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal involvement in Sjögren's syndrome.
    Bailey RR; Swainson CP
    N Z Med J; 1986 Aug; 99(807):579-80. PubMed ID: 3462548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypokalemic pareses secondary to renal tubular acidosis].
    Gøransson LG; Apeland T; Omdal R
    Tidsskr Nor Laegeforen; 2000 Jan; 120(3):324-5. PubMed ID: 10827521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum in Sjögren's syndrome and its successful treatment with topical application of etanercept.
    Haridas V; Shetty P; Dsouza LC; Dinesh US; Haridas K; Bargale A
    Int J Rheum Dis; 2017 May; 20(5):657-659. PubMed ID: 28419761
    [No Abstract]   [Full Text] [Related]  

  • 12. A combination of extraglandular manifestations of Sjögren's syndrome.
    Cheah TE; Jasmin R; Sockalingam S
    Int J Rheum Dis; 2012 Dec; 15(6):e156-8. PubMed ID: 23253245
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature.
    Zhao J; Chen Q; Zhu Y; Zhao M; Liu J; Zhang Z; Gong X
    Pediatr Rheumatol Online J; 2020 May; 18(1):39. PubMed ID: 32448292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.
    Mavragani CP; Niewold TB; Moutsopoulos NM; Pillemer SR; Wahl SM; Crow MK
    Arthritis Rheum; 2007 Dec; 56(12):3995-4004. PubMed ID: 18050196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TNF-alpha inhibitors].
    Fain O
    Rev Prat; 2003 Nov; 53(18):1989-90. PubMed ID: 15008210
    [No Abstract]   [Full Text] [Related]  

  • 16. A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.
    Soy M; Pamuk ON; Gerenli M; Celik Y
    Rheumatol Int; 2005 Nov; 26(1):86-9. PubMed ID: 15690142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy.
    Nakayamada S; Fujimoto T; Nonomura A; Saito K; Nakamura S; Tanaka Y
    Rheumatology (Oxford); 2009 Oct; 48(10):1279-82. PubMed ID: 19671696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren's syndrome presenting with a minor salivary gland mass.
    Kemker BJ; Dayal VS; DeMay RM
    J Otolaryngol; 1998 Oct; 27(5):298-300. PubMed ID: 9800630
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.
    Cantarini L; Tinazzi I; Caramaschi P; Bellisai F; Brogna A; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(2):551-5. PubMed ID: 19505410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid improvement of osteomalacia by treatment in a case with Sjögren's syndrome, rheumatoid arthritis and renal tubular acidosis type 1.
    Okada M; Suzuki K; Hidaka T; Shinohara T; Kataharada K; Matsumoto M; Takada K; Ohsuzu F
    Intern Med; 2001 Aug; 40(8):829-32. PubMed ID: 11518137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.